Call Options Transactions Made in Q3 2024 in Ligand Pharmaceuticals Inc (LGND)
This table provides information about the institutional ownership of Ligand Pharmaceuticals Inc (LGND) during Q3 2024. The information is specifically focused on institutions that hold call options of LIGAND PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
2.2KNew |
$182K - $242K
|
2.2K
$252K
|
|
Nov 13, 2024
Q3 2024
|
Brant Point Investment Management LLC
New York, NY |
BUY
|
CALL |
200New |
$16.5K - $22K
|
200
$22.9K
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
100New |
$8.27K - $11K
|
100
$11.5K
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-15.3K- 58.62% |
$1.27M - $1.68M
|
10.8K
$1.24M
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-21.4K- 61.32% |
$1.77M - $2.36M
|
13.5K
$1.55M
|